Toby A. Eyre MBChB, DipMedEd, MRCP, FRCPath, MD

Dr. Toby Eyre is a consultant haematologist at Oxford University Hospitals NHS Foundation Trust specializing in the management of lymphoid malignancies. He is an expert in the management of patients with lymphoma and patients with chronic lymphocytic leukemia.

Dr. Eyre has completed an MD Doctorate Thesis in early phase trials and biomarker studies in aggressive lymphoid disease in 2017. He completed his haematology training in the Oxford Deanery between 2010 and 2017. He is an investigator on a number of national UK lymphoma and chronic lymphocytic leukaemia trials and has published over 110 peer-review articles on areas of lymphoma and CLL and has presented regularly at national and international conferences.

He is a core member of the low-grade lymphoma and elderly high-grade lymphoma NCRI clinical studies group and a member of the BSCH guideline writing groups for various lymphoma subtypes. He is a member of the BSH Haemato-Oncology Task Force and a CLL Forum executive committee. He also has a strong interest in teaching and training and has completed a post-graduate Diploma in Medical Education.​ He is the current BSH-NIHR Researcher of the year in 2021.